Key result
Peripartum cardiomyopathy has an incidence in the United States of 1 per 3000 to 4000 live births and is defined clinically as the onset of cardiac failure around the time of delivery.
Provides a standardized clinical definition of peripartum cardiomyopathy established by an NHLBI workshop.
Standardizes peripartum cardiomyopathy diagnosis; leaves open prospective validation of incidence and outcomes.
Peripartum cardiomyopathy is a poorly understood condition whose incidence in the United States is 1 per 3000 to 4000 live births.1 Previous descriptions of the disorder were based on a vague definition derived from a heterogeneous group of patients,2 but in 1997, the participants in a National Heart, Lung, and Blood Institute (NHLBI) workshop agreed on a standardized definition.3 Peripartum cardiomyopathy was defined clinically as the onset of cardiac failure with no identifiable cause in the last month of pregnancy or within five months after delivery, in the absence of heart disease before the last month of pregnancy. The finding . . .
No takes yet. Share an insight, caveat, or question.
Reimold et al. (2001) conducted a review in Peripartum cardiomyopathy. Peripartum cardiomyopathy has an incidence in the United States of 1 per 3000 to 4000 live births and is defined clinically as the onset of cardiac failure around the time of delivery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: